Metabolic Profiling and Combined Therapeutic Strategies Unveil the Cytotoxic Potential of Selenium-chrysin (SeChry) in NSCLC Cells

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2024 Jul 11

PMID 38990147

Authors

Cindy Mendes

Isabel Lemos

Ana Hipolito

Bruna Abreu

Catarina Freitas-Dias

Filipa Martins

Rita F Pires

Helio Barros

Vasco D B Bonifacio

Luis G Goncalves

Jacinta Serpa

Affiliations

Soon will be listed here.

Abstract

Lung cancer ranks as the predominant cause of cancer-related mortalities on a global scale. Despite progress in therapeutic interventions, encompassing surgical procedures, radiation, chemotherapy, targeted therapies and immunotherapy, the overall prognosis remains unfavorable. Imbalances in redox equilibrium and disrupted redox signaling, common traits in tumors, play crucial roles in malignant progression and treatment resistance. Cancer cells, often characterized by persistent high levels of reactive oxygen species (ROS) resulting from genetic, metabolic, and microenvironmental alterations, counterbalance this by enhancing their antioxidant capacity. Cysteine availability emerges as a critical factor in chemoresistance, shaping the survival dynamics of non-small cell lung cancer (NSCLC) cells. Selenium-chrysin (SeChry) was disclosed as a modulator of cysteine intracellular availability. This study comprehensively characterizes the metabolism of SeChry and investigates its cytotoxic effects in NSCLC. SeChry treatment induces notable metabolic shifts, particularly in selenocompound metabolism, impacting crucial pathways such as glycolysis, gluconeogenesis, the tricarboxylic acid (TCA) cycle, and amino acid metabolism. Additionally, SeChry affects the levels of key metabolites such as acetate, lactate, glucose, and amino acids, contributing to disruptions in redox homeostasis and cellular biosynthesis. The combination of SeChry with other treatments, such as glycolysis inhibition and chemotherapy, results in greater efficacy. Furthermore, by exploiting NSCLC's capacity to consume lactate, the use of lactic acid-conjugated dendrimer nanoparticles for SeChry delivery is investigated, showing specificity to cancer cells expressing monocarboxylate transporters.

References

Li X, Yang Y, Zhang B, Lin X, Fu X, An Y . Lactate metabolism in human health and disease. Signal Transduct Target Ther. 2022; 7(1):305. PMC: 9434547. DOI: 10.1038/s41392-022-01151-3. View

Serpa J . Cysteine as a Carbon Source, a Hot Spot in Cancer Cells Survival. Front Oncol. 2020; 10:947. PMC: 7344258. DOI: 10.3389/fonc.2020.00947. View

Curtis N, Mooney L, Hopcroft L, Michopoulos F, Whalley N, Zhong H . Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity. Oncotarget. 2017; 8(41):69219-69236. PMC: 5642474. DOI: 10.18632/oncotarget.18215. View

Cai X, Wang C, Yu W, Fan W, Wang S, Shen N . Selenium Exposure and Cancer Risk: an Updated Meta-analysis and Meta-regression. Sci Rep. 2016; 6:19213. PMC: 4726178. DOI: 10.1038/srep19213. View

Wiel C, Le Gal K, Ibrahim M, Jahangir C, Kashif M, Yao H . BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis. Cell. 2019; 178(2):330-345.e22. DOI: 10.1016/j.cell.2019.06.005. View

Bevinakoppamath S, Saleh Ahmed A, Ramachandra S, Vishwanath P, Prashant A . Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast Cancer. Front Pharmacol. 2021; 12:618172. PMC: 8087246. DOI: 10.3389/fphar.2021.618172. View

Zhenyukh O, Civantos E, Ruiz-Ortega M, Sanchez M, Vazquez C, Peiro C . High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation. Free Radic Biol Med. 2017; 104:165-177. DOI: 10.1016/j.freeradbiomed.2017.01.009. View

Shimada B, Swanson S, Toh P, Seale L . Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers. Biomolecules. 2022; 12(11). PMC: 9687593. DOI: 10.3390/biom12111581. View

Jardim-Messeder D, Moreira-Pacheco F . 3-Bromopyruvic Acid Inhibits Tricarboxylic Acid Cycle and Glutaminolysis in HepG2 Cells. Anticancer Res. 2016; 36(5):2233-41. View

10.

Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F . Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 2023; 11(11):e1700-e1712. PMC: 10581909. DOI: 10.1016/S2214-109X(23)00406-0. View

11.

Mok T, Wu Y, Thongprasert S, Yang C, Chu D, Saijo N . Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009; 361(10):947-57. DOI: 10.1056/NEJMoa0810699. View

12.

Bola B, Chadwick A, Michopoulos F, Blount K, Telfer B, Williams K . Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport. Mol Cancer Ther. 2014; 13(12):2805-16. PMC: 4258406. DOI: 10.1158/1535-7163.MCT-13-1091. View

13.

Wang M, Herbst R, Boshoff C . Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021; 27(8):1345-1356. DOI: 10.1038/s41591-021-01450-2. View

14.

Lee J, Kim W, Bae K, Lee S, Lee E . Lipid Metabolism and Ferroptosis. Biology (Basel). 2021; 10(3). PMC: 8000263. DOI: 10.3390/biology10030184. View

15.

Pouyssegur J, Marchiq I, Parks S, Durivault J, Zdralevic M, Vucetic M . 'Warburg effect' controls tumor growth, bacterial, viral infections and immunity - Genetic deconstruction and therapeutic perspectives. Semin Cancer Biol. 2022; 86(Pt 2):334-346. DOI: 10.1016/j.semcancer.2022.07.004. View

16.

Bridgewater H, Bolitho E, Romero-Canelon I, Sadler P, Coverdale J . Targeting cancer lactate metabolism with synergistic combinations of synthetic catalysts and monocarboxylate transporter inhibitors. J Biol Inorg Chem. 2023; 28(3):345-353. PMC: 10036267. DOI: 10.1007/s00775-023-01994-3. View

17.

Zheng R, Chen Z, Guan Z, Zhao C, Cui H, Shang H . Variable importance for projection (VIP) scores for analyzing the contribution of risk factors in severe adverse events to Xiyanping injection. Chin Med. 2023; 18(1):15. PMC: 9923652. DOI: 10.1186/s13020-023-00718-8. View

18.

Tyagi R, Chakraborty S, Tripathi S, Jung I, Kim S, Snyder S . Inositol polyphosphate multikinase modulates redox signaling through nuclear factor erythroid 2-related factor 2 and glutathione metabolism. iScience. 2023; 26(7):107199. PMC: 10345128. DOI: 10.1016/j.isci.2023.107199. View

19.

Gray L, Tompkins S, Taylor E . Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci. 2013; 71(14):2577-604. PMC: 4059968. DOI: 10.1007/s00018-013-1539-2. View

20.

Zhao G, Wu X, Chen P, Zhang L, Yang C, Zhang J . Selenium nanoparticles are more efficient than sodium selenite in producing reactive oxygen species and hyper-accumulation of selenium nanoparticles in cancer cells generates potent therapeutic effects. Free Radic Biol Med. 2018; 126:55-66. DOI: 10.1016/j.freeradbiomed.2018.07.017. View